Ab Studio designed antibodies are at clinical stages! GB261, an Fc-Function Enabled and CD3 Affinity De-Tuned CD20/CD3 Bispecific Antibody designed by Ab Studio shows promising new results published in ASH's annual meeting. Click here for more information.
Using our proven technology of computer-design and on-bench validation, SEND US YOUR PROTEIN SEQUENCE and we will provide a drug candidate OFFERING IMPROVED BALANCE OF SAFETY, EFFICACY, AND MANUFACTURABILITY.
Ab Studio Inc. is a biotech startup founded in the San Francisco Bay Area in 2017. Founder, Yue Liu, is a leading scientist with extensive expertise in therapeutic antibody discovery and computer-aided design. Joining Yue, the team is composed of experts in antibody engineering, B-cell cloning, cancer biology, immunology and virology.Meet Our Team